The landscape of dementia prognosis has progressed substantially with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years before symptoms arise. Even though these technological improvements characterize amazing progress in comprehending neurodegenerative diseases, they may have not https://jaroslavj419hsc9.ssnblog.com/profile